These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 6152634

  • 1. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
    Devynck MA, de The H, Pernollet MG, Cloix JF, Rosenfeld JB, Kamal LA, Meyer P.
    J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634
    [Abstract] [Full Text] [Related]

  • 2. Plasma endogenous sodium pump inhibitor in essential hypertension.
    Cloix JF, Devynck MA, Elghozi JL, Kamal LA, Lacerda-Jacomini LC, Meyer P, Pernollet MG, Rosenfeld JB, De Thé H.
    J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
    [Abstract] [Full Text] [Related]

  • 3. [Circulating inhibitor of the Na+-K+ pump in essential hypertension. Physiological and pharmacological variations].
    Pernollet MG, de Thé H, Delva P, Wauquier I, Devynck MA, Baudouin-Legros M, Deray G, Rosenfeld J, Meyer P.
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1283-7. PubMed ID: 6098238
    [Abstract] [Full Text] [Related]

  • 4. Chemical, experimental, and clinical studies on endogenous ouabain-like substance in hypertension.
    Cloix JF, Crabos M, Devynck MA, Elghozi JL, Henning G, Kamal LA, Lacerda-Jacomini LC, Meyer P, Pernollet MG, Rosenfeld JB.
    Adv Nephrol Necker Hosp; 1985 Oct; 14():161-71. PubMed ID: 2579533
    [Abstract] [Full Text] [Related]

  • 5. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF, Crabos M, Grichois ML, Guicheney P, Meyer P.
    Klin Wochenschr; 1987 Oct; 65 Suppl 8():146-53. PubMed ID: 3037183
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
    Maslova MN, Ogorodnikova LE, Titkov IuS.
    Fiziol Zh SSSR Im I M Sechenova; 1991 Sep; 77(9):232-7. PubMed ID: 1666609
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Circulating digitalis-like compounds in essential hypertension.
    Devynck MA, Pernollet MG, Cloix JF, de The H, Kamal L, Elghozi JL, Rosenfeld J, Meyer P.
    Clin Exp Hypertens A; 1984 Sep; 6(1-2):441-53. PubMed ID: 6321068
    [Abstract] [Full Text] [Related]

  • 13. [Presence and regulation of plasma with natriuretic and Na-K ATPase inhibitory properties in normotensive subjects].
    Krzesinski JM, Potier JP, Godon JP, Rorive GL.
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):960-5. PubMed ID: 2821949
    [Abstract] [Full Text] [Related]

  • 14. [Chronic dietary sodium overload and release of a circulating Na+-K+ pump inhibitor].
    Wauquier I, Guicheney P, Delva P, Grichois ML, Devynck MA.
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1716-9. PubMed ID: 3006622
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cellular mechanism relating sodium and potassium to hypertension.
    Zhao GS, Li DY, Zhu DL, Kong DW, Qian YW, Li DP.
    Ann Clin Res; 1984 Oct; 16 Suppl 43():55-61. PubMed ID: 6100156
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Recent progress on an endogenous digitalislike factor in hypertension.
    Cloix JF, Crabos M, Meyer P.
    J Clin Hypertens; 1986 Jun; 2(2):93-100. PubMed ID: 3020179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.